Top Story

Vaccine shows promise against chikungunya

August 19, 2014

An investigational vaccine using non-infectious virus-like particles demonstrated protection against chikungunya virus, according to data published in The Lancet.

“Since 2006, the virus has caused outbreaks of the disease where it had never been previously reported, including Italy, France, and most recently, the United States,” Julie Ledgerwood, DO, chief of the clinical trials program in the vaccine research center at the National Institute of Allergy and Infectious Diseases, said in a press release. “Currently, we have no licensed vaccines or approved drugs for this debilitating infection, which causes fever and intensely painful, severe arthritis.”

figure Industry News

World Hepatitis Alliance launches HCV Quest

August 19, 2014
The World Hepatitis Alliance has created HCV Quest, a global survey that provides a forum for patients with hepatitis C virus, according to an announcement on the…
In the Journals

Rifamycin regimens most effective against latent TB

August 19, 2014
In patients with latent tuberculosis infection, treatment regimens that included at least 3 months of rifamycin were most effective at preventing active disease…
figure Meeting News Coverage

Oral microbiome-based therapeutic safely treated C. difficile infection

August 19, 2014
A novel oral microbial therapeutic safely and effectively treated recurrent Clostridium difficile infection, according to results from a phase 1/2 clinical study…
More News Headlines »

HCV Consults: Volume 1, Number 1

This activity is supported by educational grants from AbbVie and Genentech.

Physicians seldom experience a paradigm shift in disease management as great as that transpiring in HCV therapy. With…
More »

Gene surgery effectively removes HIV-1 from human cells

July 29, 2014
PHILADELPHIA — Temple University researchers have successfully eradicated latent HIV-1 virus from cultured human…
More »

HPV Disease Update 2013: What Every Pediatric Health Care Professional Needs to Know

This activity is supported by an educational grant from Merck & Co., Inc.

This CME-certified activity is based on the slides and lectures of faculty presenting at the Infectious Diseases in
More »